Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiren Huang

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Molecular Biosystems|March 25, 2015
Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637Xing Fu, Yuchen Liu, Chengle Zhuang, et al.
STAR Protocols|January 11, 2021
Protocol for generation of lung adenocarcinoma organoids from clinical samplesZhichao Li, Lei Yu, Dong Chen, et al.
Genome Biology|June 5, 2019
Multiplexed promoterless gene expression with CRISPReaderHengji Zhan, Qun Zhou, Qunjun Gao, et al.
Oncotarget|November 2, 2017
Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysisDailian Wang, Zhicong Chen, Haidan Xu, et al.
Cell Death & Disease|March 5, 2026
Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerabilityChengjiao Yang, Ruici Yang, Binbin Zheng, et al.
Journal of Cancer|July 21, 2018
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease TreatmentMengting Ding, Yuhan Liu, Xinhui Liao, et al.
Oncotargets and Therapy|March 14, 2019
Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancerZhicai Wang, Qun Zhou, Aolin Li, et al.
Bioorganic Chemistry|January 1, 2024
Near-infrared light controlled protein degradation by photo-caged lenalidomide and pomalidomideYaoji Zhu, Xiaosa Yan, Yinan Shi, et al.
Frontiers in Physiology|November 23, 2017
Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-AnalysisQunjun Gao, Haibiao Xie, Hengji Zhan, et al.
ACS Applied Materials & Interfaces|January 29, 2021
CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug DeliveryYingxin Ma, Guobin Mao, Guoqiang Wu, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Molecular Biosystems|March 25, 2015
Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637Xing Fu, Yuchen Liu, Chengle Zhuang, et al.
STAR Protocols|January 11, 2021
Protocol for generation of lung adenocarcinoma organoids from clinical samplesZhichao Li, Lei Yu, Dong Chen, et al.
Genome Biology|June 5, 2019
Multiplexed promoterless gene expression with CRISPReaderHengji Zhan, Qun Zhou, Qunjun Gao, et al.
Oncotarget|November 2, 2017
Long noncoding RNA CCAT2 as a novel biomaker of metastasis and prognosis in human cancer: a meta-analysisDailian Wang, Zhicong Chen, Haidan Xu, et al.
Cell Death & Disease|March 5, 2026
Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerabilityChengjiao Yang, Ruici Yang, Binbin Zheng, et al.
Journal of Cancer|July 21, 2018
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease TreatmentMengting Ding, Yuhan Liu, Xinhui Liao, et al.
Oncotargets and Therapy|March 14, 2019
Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancerZhicai Wang, Qun Zhou, Aolin Li, et al.
Bioorganic Chemistry|January 1, 2024
Near-infrared light controlled protein degradation by photo-caged lenalidomide and pomalidomideYaoji Zhu, Xiaosa Yan, Yinan Shi, et al.
Frontiers in Physiology|November 23, 2017
Prognostic Values of Long Noncoding RNA GAS5 in Various Carcinomas: An Updated Systematic Review and Meta-AnalysisQunjun Gao, Haibiao Xie, Hengji Zhan, et al.
ACS Applied Materials & Interfaces|January 29, 2021
CRISPR-dCas9-Guided and Telomerase-Responsive Nanosystem for Precise Anti-Cancer Drug DeliveryYingxin Ma, Guobin Mao, Guoqiang Wu, et al.
Pageof 13